探讨过敏性紫癜的发病特点及防治规律
Discussion on the Characteristics of the Pathogenesis of Allergic Purpura and the Rules of Prevention and Treatment
DOI: 10.12677/acm.2024.1461770, PDF,   
作者: 孟凡顺, 赵 平, 杨 岩*:黑龙江省中医药科学院研究生院,黑龙江 哈尔滨;张凯悦, 王天恩:黑龙江中医药大学附属第一医院继续教育科,黑龙江 哈尔滨
关键词: 过敏紫癜发病特点防治规律Allergy Purpura Morbidity Characteristics Prevention and Treatment Rules
摘要: 本文深入探讨了过敏性紫癜的发病特点及防治规律。过敏性紫癜由多种病因引发,包括感染、药物、食物和其他环境因素,其发病机制主要涉及免疫反应和血管炎症。临床表现多样,典型症状包括皮肤紫癜、关节疼痛或肿胀、胃肠道症状及肾脏受累。在防治方面,预防策略强调避免感染、谨慎用药、健康饮食和改善生活环境。治疗方法涵盖急性期治疗、慢性期管理以及替代疗法。病情监测与管理强调定期随访、症状观察和肾功能监测。结论指出,理解过敏性紫癜的发病特点对制定有效的防治策略至关重要,而遵循防治规律对于控制病情、减轻症状及预防复发具有显著意义。
Abstract: This article provides an in-depth discussion of the pathogenetic features of allergic purpura and the rules of prevention and treatment. Allergic purpura is triggered by a variety of etiologic factors, including infections, drugs, food and other environmental factors, and its pathogenesis mainly involves immune response and vascular inflammation. Clinical manifestations are diverse and typical symptoms include skin purpura, joint pain or swelling, gastrointestinal symptoms and renal involvement. In terms of prevention and treatment, preventive strategies emphasize avoidance of infection, careful use of medication, healthy diet and improvement of the living environment. Therapeutic approaches cover acute phase treatment, chronic phase management, and alternative therapies. Disease monitoring and management emphasized regular follow-up, symptomatic observation, and renal function monitoring. It was concluded that understanding the pathogenetic characteristics of purpura is essential for developing effective prevention and treatment strategies, and following the prevention and treatment protocols is significant for controlling the disease, reducing symptoms, and preventing relapses.
文章引用:孟凡顺, 张凯悦, 赵平, 王天恩, 杨岩. 探讨过敏性紫癜的发病特点及防治规律[J]. 临床医学进展, 2024, 14(6): 255-259. https://doi.org/10.12677/acm.2024.1461770

参考文献

[1] 韩树凤, 杨金艳, 冷红梅. 药物过敏致过敏性紫癜及咯血1例[J]. 中外医学研究, 2013, 11(1): 154.
[2] 张珍. 当代名中医治疗紫癜性肾炎规律的研究[D]: [硕士学位论文]. 成都: 成都中医药大学, 2013.
[3] 于斌, 郭培京, 杨红蓉. 血清学检测过敏原对过敏性紫癜的防治意义[J]. 山西医药杂志(下半月刊), 2013, 42(12): 1434-1435.
[4] 王慧玉. 抗过敏联合消斑饮治疗过敏性紫癜临床观察[J]. 浙江中西医结合杂志, 2015, 25(8): 768-770.
[5] 朱广. 过敏性紫癜的诊断与治疗[J]. 中国处方药, 2016, 14(12): 144.
[6] 温慧萍, 吕新芝, 周婉萍, 等. 复方泛影葡胺致碘过敏试验阴性患者过敏性紫癜1例[J]. 药物流行病学杂志, 2021, 30(5): 357-358.
[7] 邢亚萍, 韩姗姗, 丁樱, 等. 基于“阳明有余”探讨“肠道微生态-免疫炎症”失衡在腹型过敏性紫癜中的作用[J]. 中国中医基础医学杂志, 2023, 29(12): 2038-2041.
[8] 余明寰, 孙原婷, 罗懿, 等. 国医大师郑新辨治过敏性紫癜肾炎经验[J]. 中国中医急症, 2024, 33(3): 529-532.
[9] 任瑞华, 罗沙沙, 钟小明. 过敏性紫癜发病机制的研究进展[J]. 赣南医学院学报, 2023, 43(10): 1080-1083.
[10] 魏慧, 次旦央宗, 益西拉姆, 等. 高原地区不同类型过敏性紫癜藏族患者发病的相关危险因素[J]. 北京大学学报(医学版), 2023, 55(5): 923-928.
[11] 张雪杨. 过敏性紫癜中医证型分布与复发危险因素的研究[D]: [硕士学位论文]. 新疆: 新疆医科大学, 2023.
[12] 潘聪, 赖文英, 毛静媛, 等. 血清25-(OH)D水平与过敏性紫癜并发肾损害的相关性分析[J]. 临床医学研究与实践, 2022, 7(6): 12-14.
[13] Ozen, S., et al. (2014) EULAR/PRIDE Recommendations for the Management of Henoch-Schonlein Purpura and IgA Vasculitis. Rheumatology (Oxford), 53, 1078-1088.
[14] Xu, H., et al. (2010) Henoch-Schonlein Purpura Nephritis: A Retrospective Cohort Study of 197 Patients. American Journal of Kidney Diseases, 55, 303-312.
[15] 石健, 张骋. 过敏性紫癜病因及发病机制的研究[J]. 医学信息, 2022, 35(4): 49-52.